BRAVECTO® 1-MONTH Chews for Dogs and Puppies
Get Bravecto® 1-month chews for your dog or puppy for 100 percent effective and easy protection against fleas and ticks.
LEARN MOREBRAVECTO® Chews for Dogs
Bravecto® (fluralaner) is a chewable flea and tick protection for dogs with persistent efficacy and 12-week protection.
LEARN MOREBRAVECTO® Topical Solution for Dogs
A fast-acting flea and tick protection in an easy-to-administer topical solution for dogs for up to 12 weeks with just one dose.
LEARN MORESCHIRMER TEAR TEST
Used in the evaluation of canine conjunctivitis to diagnose tear deficiency as a contributing factor to ocular surface diseases and to assess lacrimal gland function.
LEARN MORESALIX® (furosemide tablets) – Canine & Feline
Salix is a diuretic-saluretic used for edema associated with cardiac insufficiency and acute non-inflammatory tissue edema in dogs and cats.
LEARN MORESALIX® (furosemide injection) – Canine & Feline
Salix is a diuretic-saluretic used for edema associated with cardiac insufficiency and acute non-inflammatory tissue edema in dogs and cats.
LEARN MORENOBIVAC® Canine 1-DAPPv+Cv
For the vaccination of healthy dogs against canine distemper virus, adenovirus (Types 1 and 2), CPIV, CPV and canine coronavirus.
LEARN MORENOBIVAC® Canine 1-DAPPv+L₄
For the vaccination of healthy dogs against canine distemper virus, CPIV, CPV and Leptospirosis.
LEARN MORENOBIVAC® Canine 1-DAPPv
For vaccination of healthy dogs against canine distemper virus, canine adenovirus (Types 1 and 2), CPIV and CPV.
LEARN MORENobivac® Canine 1-Cv
For the vaccination of healthy dogs, designed to enhance the immune response and offer protection against canine coronavirus.
LEARN MORENobivac® 3-Rabies CA
NOBIVAC 3-RABIES CA vaccine meets state guidelines and is approved for sale in California to protect pets against rabies.
LEARN MORENOBIVAC® 3-Rabies
NOBIVAC 3-RABIES vaccine provides protection against rabies in dogs and cats for at least three years, and ferrets for one year.
LEARN MORE
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global